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Abstract The medical management of differences of sex
development (DSD)/intersex in early childhood has been
criticized by patients’ advocates as well as bioethicists from
an ethical point of view. Some call for a moratorium of any
feminizing or masculinizing operations before the age of
consent except for medical emergencies. No exhaustive
ethicalguidelineshavebeenpublisheduntilnow.Inparticular,
the role of the parents as legal representatives of the child is
controversial. In the article, we develop, discuss, and present
ethical principles and recommendations for the medical
management of intersex/DSD in children and adolescents.
We specify three basic ethical principles that have to be
respected and substantiate them. The article includes a critical
discussion of the best interest of the child and of family
privacy. The argumentation draws upon recommendations by
the working group “Bioethics and Intersex” within the
GermanNetworkDSD/Intersex,whicharepresentedindetail.
Unlike other recommendations with regard to intersex, these
guidelinesrepresentacomprehensiveviewoftheperspectives
of clinicians, patients, and their families.
Conclusion The working group identified three leading
ethical principles that apply to DSD management: (1) to
foster the well-being of the child and the future adult, (2) to
uphold the rights of children and adolescents to participate
in and/or self-determine decisions that affect them now or
later, and (3) to respect the family and parent–child
relationships. Nine recommendations for the management
of DSD indicate how these ethical principles can spelled
out and balanced against each other in the clinical setting.
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Differences of sex development (DSD)
1—or intersex as it is
sometimes called—has recently attracted considerable
1 The term DSD meaning disorders of sex development was coined by
the International Consensus Conference (2006). The notion “disor-
ders,” however, is criticized for its pathologizing tendency. In this
paper, we use the terms “differences in sex development” or “intersex”
to avoid a biased opinion. The field of intersex shows a wide range of
variations from the statistically normal. We understand that in Western
societies, there is a ongoing debate on which variations of sex
development should be classified as male or female, normal or not
normal, in need of a medical intervention or not, disorder or
difference. This debate is unlikely to come to an end soon. For
example, homosexuality was treated as a biological and psychological
abnormality of sexual development, but is no longer today. Normality
in medicine is a biological as well as a social criterion, and its
meaning is changing over time. The notion “disease” or “disorder”
implies that something is a relevant abnormality and that medicine is
in charge of it. We want to avoid this reflex. However, we do not deny
that there may be conditions requiring medical intervention.
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and geneticists, as well as feminists, ethicists, and self-help
groups [1–6]. A number of articles have been published to
clarify the role medicine should play in shaping sex and
gender identity in children with DSD. The new literature
indicates a shift of the paradigm of a so-called “optimal-
gender policy,” a term coined by the early pioneering group
in the field from Johns Hopkins University in the 1960s. At
the time, early corrective surgery was thought to help the
affected children as well as their parents to facilitate stable
gender identity and appropriate gender role behavior [7–9].
Sex assignment of infants with ambiguous genitalia often
resulted in feminizing operations in moderate or severe
undervirilization in 46,XY DSD as well as 46,XX con-
ditions with severe masculinization. Those critical of early
surgery aiming at normal or near normal appearance argue
that the complexity of gender identity was not considered
adequately, and the mutilating and traumatizing effects of
treatment were not sufficiently taken into account. Other
than in the case of medical emergencies, they now advocate
a moratorium in any feminizing or masculinizing operations
before full consent may be obtained from the child [10, 11].
This strategy can be called “full-consent policy.”
Today, guidelines from medical societies still endorse
techniques like clitoris reduction or vagina surgery in the
newborn or infant, albeit more cautiously than before [12,
13]. However, the underlying ethical principles of DSD
management have not been seriously scrutinized since
Kenneth Kipnis and Milton Diamond’s harsh criticism in
the J o u r n a lo fC l i n i c a lE t h i c sof the “optimal-gender
policy,” particularly for the deficiencies in informed
decision making [11]. In 2004, an ad hoc group at the
Hastings Center for Bioethics comprising clinicians, phi-
losophers, and bioethicists, called for a multidisciplinary
approach to the management of DSD, the child’s right to
know and rigorous follow-up studies but avoided tackling
the contentious issue of decision making in early childhood
[14]. A Consensus Statement on Management of Intersex
Disorders issued by the participants of an International
Consensus Conference in 2006 involving pediatric special-
ists from the United States, Great Britain, and Germany
endorsed open communication, a reflective stance on
gender identity and a focus on quality of life issues—
encompassing “falling in love, dating, attraction, ability to
develop intimate relationship, sexual functioning, and the
opportunity to marry and raise children”—rather than the
biological indicators of sex [15]. This statement offers a
thorough appraisal of clinical procedures and psychosocial
requirements but fails to give sound ethical arguments for
the proposed strategies.
The aim of this paper is to identify and critically discuss
those ethical principles that should be respected in medical
decision making. Our argumentation draws upon the
recommendations by the working group “Bioethics and
Intersex” within the German Network DSD/Intersex, which
are presented and developed in detail. We will delineate
how the rights of the child and the future adult can best be
defended by exploring the meaning of patient autonomy.
We will also show why a moratorium on nonemergency
intersex surgery in early childhood is not justified from an
ethical point of view, and why family privacy has to be
taken into account.
Working group “bioethics and intersex”
within the German Network DSD/Intersex
Since 2004, a research network on DSD/intersex has been
in operation in Germany, funded by the German Ministry
of Education and Research within the research program
for rare diseases. As part of the network, a working group
“Bioethics and Intersex” was established to discuss
guiding ethical principles and develop ethical guidelines
for the clinical management of children with ambiguous
genitalia.
The working group adopted a catalog of “Ethical
principles and recommendations for the therapeutic man-
agement of differences of sex development (DSD)/Inter-
sexuality in children and adolescents” outlined below. The
working group consisted of members of patient support
groups (persons with DSD/intersex and/or parents); bio-
ethicists; specialists in pediatrics and adolescent medicine,
surgery, urology, obstetrics and gynecology, endocrinology;
a psychologist and psychotherapist; a specialist in medical
law; and a medical sociologist. In a series of meetings, they
familiarized themselves with the ethical, legal, psychosocial,
and medical aspects concerning this subject and communi-
cated with numerous experts in the field. The working group
critically reviewed the diagnostic and therapeutic options
available for individuals with ambiguous genitalia in the light
of common bioethical principles. We have
– analyzed the concepts of health, disease, and quality of
life with respect to interventions in persons with
discordant chromosomal, gonadal, and anatomical
sex, but without any acute health risks;
– delineated the fundamental conflicts and ethical princi-
ples which should guide any medical and surgical
interventions;
– established the rights of children and the rights and
duties of the parents and health-care teams with regard
to these issues and developed a standard for decision
making (based on informed consent).
A draft of the ethical principles and recommendations
designed for the health-care team has been submitted to all
members of the network for feedback and discussion.
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contentious?
The ethics work group identified four scientific and social
tendencies as the major driving forces that led to a
thorough reappraisal of former treatment regimes in DSD:
(1) increasing knowledge about sex determination and
differentiation and the complicated interaction of genotype
and phenotype; (2) modern society’s decreasing rigidity
about the nature of sexual identity and gender roles
following the women’s liberation movement; (3) a
growing unease about paternalism in medicine along with
the advocacy of patients’ and children’s rights; and (4) the
growing importance of patient support groups in the
assessment of medical interventions. These factors have
helped to re-evaluate the rationality of the “optimal-gender
policy,” once recommended by John Money and others.
This strategy aimed at benefiting the child as well as the
family by creating social certainty through surgical
interventions “normalizing” the appearance of the external
genitalia. At the time, the impact of hormones on the
brain and other organs was underestimated, and the social
impact of the stigma of being different was believed to
create great distress for individuals affected by DSD. The
concept has meanwhile fallen short of expectations. Its
major shortcomings included: it was based on less than
satisfactory scientific evidence of the long-term outcomes;
it privileged phenotypic normalcy over bodily integrity
and—to some extent also—quality of life; it systematical-
ly neglected the trauma inflicted on the child by medical
interventions; and it often meant that neither the child and
the future adult nor the parents were educated about the
nature of the disorder and the purpose and extent of medical
interventions. The last aspect—the secrecy within families
and lack of informed consent even in adolescents—is
in fact now considered the most problematic issue, as it
immunized physicians’ and parents’ convictions from being
falsified.
Meanwhile, intersex activists and the medical commu-
nity itself have demanded for more evidence on the long-
term outcome with regard not just to appearance but also to
sexual satisfaction, reproductive functions, gender identity,
and quality of life. As these data can only be provided
when the patients and their families are fully informed
about their condition, optimal gender policy has lost its
attractiveness as a comprehensive and successful strategy
for managing DSD.
Patient autonomy and postponed informed consent
Some critics believe that informed consent by patients is the
only way to legitimate appearance-normalizing surgery in
DSD. Given the importance of this ethical concept in
modern medicine, this is no surprise [15]. Without the
competent patient’s informed consent, a medical interven-
tion amounts to battery [16]. Critics of early surgical
interventions have cast doubt on parental surrogate decision
making. Parents’ surrogacy, they argue, should extend
merely to decisions that are in the objective best interest
of the child [17, 18]. The appearance of the external
genitalia in DSD generally causes no medical problems or
immediate health threats to the child. Moreover, most
surgical interventions are irreversible and may restrict later
options for sex reversal. As it is difficult to find out what is
in the best interest of the child, nobody, the argument goes,
should decide on these important questions except the
patient him/herself. This position entails postponing minor
interventions at least until the age of 5 or 6, when the child
is able to express preferences and major interventions until
the age of 12 to 14.
Although appealing in its simplicity, the argument,
however, is flawed: it does not sufficiently distinguish
between the interests of the child, particularly the small
one, and those of the future adult. That which benefits the
child at the age of 3 or 4 and the teenager or adult at 15
or 20, might not be identical at all. Whereas the small
child might depend upon a stable gender identity role and
undisturbed relations to his or her peers and prefer
conformity over independence, the young grown-up might
cherish authenticity, independence, and the right freely to
choose relationships that suit him or her well. According
to the maxim of postponed informed consent, only the
adult would be truly able to determine the best interests of
the child he or she was in a former time. But this child no
longer exists, and its interests, thus, can no longer be
respected.
For example, a child with incomplete Androgen Insen-
sitivity Syndrome raised as a girl might in puberty face the
effects of virilizing hormones. Hormone suppression has to
start before puberty to avoid the effects of male-typical
pubertal development and to prevent major disturbances in
gender identity. Postponing this decision to the age of
consent, however, means closing an important window of
opportunity for the child. The future adult’s consent, thus,
will be meaningless, because no decision will undo the
consequences of a waiver of treatment in the past. Like
“optimal-gender policy,” the strategy of postponed consent
also has a self-immunizing tendency, as it implicitly treats
the small child’sw i s h e sa si r r e l e v a n t .D e m a n d i n ga
surgical moratorium until the age of consent had been an
understandable reaction to nonjustified surgical optimism
in the past, but nevertheless resembles the strategy in an
old joke: A man has lost his keys in the dark, but is
looking for them under a street lamp since he would
otherwise not be able to find them.
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A sound ethical justification for treatment decisions in early
childhood is indeed the key to decision making in DSD.
The right to represent the child and to decide on its behalf is
normally accorded to the parents as legal guardians.
However, their role in DSD management is contested.
Dayner et al., e.g., showed that parents of 46,XX children
with congenital adrenal hyperplasia mostly are in favor of
early genital clitoris reduction, even at the risk of reducing
genital sensitivity, although it is not clear that this is in the
interest of the child [19]. Patient support groups argue that
“in intersex conditions the parents’ wishes often conflict
with the child’s ultimate best interest” [20, 21].
The double superlative “ultimate best,” however, hints to
some characteristic difficulties associated with the so-called
best interest standard in pediatric ethics that might step in,
in the place of informed consent. Ethicists agree upon the
fact that the lower threshold of what is definitely not in the
interest of the child can be fixed, such as anything that is
purposefully destructive or even life-threatening. They
would also agree on what counts as an ethical minimum
of parental care, such as adequate clothing, nourishment,
and education [22, 23]. However, this is far from establish-
ing an objective ethical maximum as is implied by the
notion “best” (let alone “ultimate best”) in best interest
standard. In modern pluralistic societies, there is no such
criterion as an objective best interest standard for child care.
Although quite commonly used in ethical debate, this
notion is misleading and should be abandoned because it
suggests an objective external value system with a linear
scale, which does not exist, for optimal parental behavior
[24, 25]. Parents and families are instead accorded a certain
sphere of privacy to pursue their personal aims and find out
what is their best in child care [26]. The Universal
Declaration of Human Rights, for example, acknowledges
this fact when stating: “The family is the natural and
fundamental group unit of society and is entitled to
protection by society and the State” [27]. Protection for
the child means not just protection by but also protection
from society and the state. The same attitude is expressed
by the UN Convention of the Rights of the Child. The
signing states are “convinced that the family, as the
fundamental group of society and the natural environment
for the growth and well-being of all its members and
particularly children, should be afforded the necessary
protection and assistance so that it can fully assume its
responsibilities within the community” [28].
Thus, parents take first-line responsibility in defining
what might be best for the child, and this may rightly vary
according to their individual experience and life style,
cultural expectations, and beliefs. The right to familial
privacy, however, is not unlimited. It has to comply with
the ethos of parenthood determined by the larger cultural
context, not just by the individual parents themselves. This
almost universal ethos demands both a caring and encour-
aging human relationship between parent and child and
respect for each and every child [29]. The way in which
parents are expected to live up to this ethos has to be
socially negotiated in line with social, cultural, or religious
attitudes.
The nature and extent of restrictions the state may
impose upon the family to protect children from harm and
to help parents realize the ethos of parenthood is an
ongoing controversy in modern societies. The debate on
in vitro fertilization for gay couples is one example; the
limits of parental discretion and decision making about a
child’s sex and gender identity is another.
Given the importance of supportive personal relation-
ships for children in general and the difficulties in
objectively and externally defining the child’s best interest,
parents should play a major role in the decision-making
process in DSD management. Given the complexity of
interaction between biological, psychological, social, and
cultural factors, it is also essential to make decisions on a
case-by-case basis. This forecloses such sweeping recom-
mendations for each and every case like a general
moratorium on surgical interventions in DSD in early
childhood, as well as simple formulas for the treatment of
particular disease conditions. Biological, psychological, and
social factors have an influence on the outcome of a case
and make each intersex condition unique. The individual
characteristics of the child, the family, and the social
background have a bearing on the benefits to be achieved
for the child and thus, have to be taken into account.
Nevertheless, it is necessary to outline some general
principles limiting parental discretion in accordance with
commonly shared beliefs of the good parent on one hand
and of the child’s human dignity and bodily integrity on the
other hand. First of all, the child itself is to be respected as
another major player in the decision-making process. Even
the small child can express preferences or vetoes. As early
as the age of 6 or 7, children are able to understand
biological processes or to reflect on their identity [30]. The
child, therefore, should be granted partnership status and be
involved in all examination and treatment steps, as
appropriate to his or her developmental level. This helps
to modify the family perspective usually represented by the
parents.
Secondly, all persons involved should be aware of the
fact that a good parent–child relationship is the result of a
process of continuing efforts and not just a state of mind. It
can be facilitated by appropriate therapeutic interventions.
Due to the psychosocial stress associated with DSD,
parents need help in establishing a good relationship with
their child. Psychological support should always be sought
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child and to support the child in developing supportive
relationships in the peer group. If the family’s right to
decision making is endorsed, the relationships within the
family deserve careful consideration and have to be included
in the therapeutic process. Thirdly, the outcome—as judged
by minor and adult intersex patients—of any intervention
should be continuously and carefully evaluated and inform
future treatment recommendations.
Conclusions
The working group identified three ethical principles
relevant to decision making in DSD. First of all, the well-
being of the child and of the future adult has to be fostered.
It is important to note that the surgical creation of
unambiguous external genitalia is neither necessary nor
sufficient criterion for well-being and is sometimes impos-
sible to achieve; bodily integrity and quality of life,
particularly with respect to reproductive capability as well
as the ability to experience sex, and the free development of
the child’s personality have also to be taken into account.
Secondly, the rights of the patients to participate in and/or
self-determine decisions that affect them now or later have
to be respected. This includes the right of the future adult to
be comprehensively informed about their condition and
about all interventions carried out as well as the health-care
team’s obligation to provide the appropriate information
and maintain documentation. Thirdly, family and parent–
child relationships should be fostered. Parents have the right
to represent their child in the decision-making process,
particularly when there is no clear evidence of the outcome
of medical interventions and when the interest of the small
child and the future adult might not be identical. The health-
care team has to strengthen the ability of parents to cope with
the situation and to support their child. For that purpose,
parents have to receive professional support and assistance.
The Ethics Work Group was aware of the fact that these
three principles often conflict. Nine recommendations for
the management of DSD published below indicate how they
can be balanced against each other in the clinical setting.
Decision making concerning sex assignment and conse-
quent surgical interventions are hampered by the lack of
evidence in many conditions causing ambiguous genitalia
in newborns or children during their development. All
decisions must be based on the individual’s unique condition
and prognosis from a biological and social perspective.
Thus, we foster a shift in paradigm from optimal appearance
and potential functioning to optimal emotional and social
development trying to maximize the child’s and future
adults’ participation in decision making on one hand and a
good parent–child relationship on the other.
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Addendum
Ethical Principles and Recommendations
for the Medical Management of Differences of Sex
Development (DSD)/Intersex in Children
and Adolescents
Ethics Work Group
2 in the Intersex Network “Differences
of Sex Development”
3
Introduction In medicine, “differences of sex development”
(DSD) or “intersex” are defined as a congenital mismatch
between chromosomes and the internal and external
genitalia in one person. From a biological perspective, such
conditions involve various manifestations of an incomplete
development of sex anatomy (e.g., vaginal or gonadal
agenesis) and/or of disturbances in the production or action
of sex hormones. In persons with complex hormone
disorders, other body systems may also be affected.
The principles and recommendations outlined herein
address the ethical aspects of medical interventions for
correcting atypical internal or external genitalia, whereas
they do not discuss the diseases and conditions that can
develop as sequelae of DSD. Conflicts tend to arise due to
the lack of a social environment in which children with
DSD can experience their “otherness” as normal.
2 Members of the Working Group: Prof. Claudia Wiesemann, M.D.
(Medical Ethics/Working Group leader), Andrea Dörries, M.D.
(Medical Ethics/Pediatric and Adolescent Medicine), Eva Hampel,
Ph.D. (Medical Sociology), Gerda Janssen-Schmidchen (member of a
parent’s group), Eckhard Korsch, M.D. (Pediatric Endocrinology,
Pediatric and Adolescent Medicine), Eveline Kraus-Kinsky (self-help
group member), Clothilde Leriche, M.D. (Pediatric Surgery), Eveline
Loeser, M.D. (Obstetrics and Gynecology, Pediatric and Adolescent
Gynecology), Luise Müller (Working Group coordinator), Heiko
Reutter, M.D. (self-help group member), Sonja Rothärmel, J.D.
(Medical Law), Prof. Gernot H.G. Sinnecker, M.D. (Pediatric
Endocrinology, Pediatric and Adolescent Medicine), Susanne
Ude-Koeller, Ph.D. (Medical Ethics), Knut Werner-Rosen (Psycholo-
gy/Psychotherapy), Prof. Gerhard Zöller, M.D. (Urology), and one
additional self-help group member.
3 Funded by the German Ministry of Education and Research
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genitalia, the affected persons, their families, and the
attending medical team are put in a difficult situation. Such
constellations are often identified within the first days of
the child’s birth. At this early stage, decisions have to be
made as to how to proceed without knowing what the
orientation, interests, or needs of the future adolescent and
adult will be. Irrespective of whether a choice is made in
favor of or against treatment, the path taken is virtually
always irreversible while, at the same time, interfering in
highly sensitive domains, affecting reproduction, sexuality,
physical and mental integrity, and the formation of a
person’s self-identity as well as the parent–child relation-
ship. Faced with these issues, most parents feel over-
whelmed by the magnitude of the decision they have to
make on behalf of their child. Moreover, considering the
consequences of any medical interventions taken or not, the
attending team is equally confronted with a dilemma, not
least when initiating measures and interventions that are not
substantiated by valid evidence from any long-term studies.
In spite of this, when it comes to deciding on treatment,
medical expertise is frequently given the decisive edge.
In both medical circles and among affected individuals,
it remains controversial whether these conditions, and if so,
which of them should be regarded as abnormal and as
requiring treatment. Gender identity is determined by
biological, psychological, and social factors. An assignment
to one gender, based solely on biological or morphological
criteria, does justice neither to the person’s individuality
and subjectivity nor to the fact that gender identity is
dependent upon social and psychological factors. Affected
persons and self-help organizations regard the term “inter-
sex” as overly narrow, stigmatizing, and discriminatory on
one hand, but also as a stimulus to identity formation on the
other. The term intersex is, thus, just as ambivalent as the
deviation from the sexual norm from which the word
derives its meaning.
Sexual ambiguity is not a condition requiring treatment per
se. Affected persons are not the only ones who fundamentally
question medicine’s mission to heal patients with DSD. They
experience the societal pressure for sexual differentiation into
male and female and/or for sexual unambiguousness as
pathologizing. Two different concepts of gender identity have
been proposed to explain gender deviation from the norm.
Proponents of the biological–scientific model emphasize the
consequences of prenatal genetic and hormonal influences on
sex differentiation and thus, on gender. By contrast, advocates
of the social constructivist model argue that gender differen-
tiation follows from social norms.
Starting position of the authors for these principles and
recommendations The authors of these principles and
recommendations understand the two models to be com-
plementary. Hence, the following communication on DSD
will address aspects of both concepts. They do not wish to
assign a fundamentally pathological meaning to DSD. The
concept reflects society’s norms regarding gender identity,
which are currently undergoing a historical transformation.
The authors are fully aware of the problems associated with
these issues, respect the disconcertment and the rejection
caused by foreign assignation of gender roles, and accept
that alternative concepts exist among individuals.
The authors of the principles and recommendations are
aware of the fact that the medical concept of DSD reflects
societal problems that may no longer arise with such acuity
in the future, as gender roles change. Notwithstanding the
above, it is necessary to develop options for how to act in
light of the present situation and to help today’s actors
make decisions and cope with conflicts.
The aims of these principles and recommendations These
recommendations are intended for medical professionals as
well as for all other persons involved with the diagnosis,
treatment, care, and psychosocial support of children and
adolescents with DSD. This includes persons in the
following specialties: obstetrics and midwifery, pediatric
and adolescent medicine, (pediatric) endocrinology, (pedi-
atric) surgery, (pediatric) urology, (pediatric and adolescent)
gynecology, (pediatric and adolescent) psychotherapy, and
(pediatric) nursing. The goal is to employ a sensitive and
patient-centered management once an “ambiguous sex” has
been established and to ensure that the affected persons
achieve the highest possible degree of present and future
quality of life. For this, it is imperative that the multidis-
ciplinary health-care team work in close cooperation with
the affected children and adolescents, their parents, and
self-help organizations. Still, the principles and recommen-
dations shall neither relieve the parents, as the children’s
guardians, nor the members of the multidisciplinary health-
care team from personal responsibility for their own
behavior and decision making as appropriate to each
individual case.
Guiding ethical principles These principles and recommen-
dations are built upon respect for the patient’ss e l f -
determination and upon the participatory rights of children.
They give due consideration to the well-being of the child
(including of the child’s right to a good parent–child
relationship) and regard the parents not only as the
representatives of their children in all treatment decisions,
but also as affected persons who themselves require help
and support. They take into account the fact that the process
of cultural transformation within society is characterized by
a gradual breaking of gender norms as well as a greater
tolerance for gender ambiguity in men and women.
Knowing the extent to which taboos were previously
676 Eur J Pediatr (2010) 169:671–679associated with this subject and that affected persons still
suffer stigmatization, the authors of these principles and
recommendations aim to promote professionalism, respect,
and tolerance in the management of DSD and to counteract
any stigmatizing behavior by the medical community and
society.
Upholding different ethical principles such as benefi-
cence, nonmaleficence, and patient autonomy can lead to
contradictory conclusions concerning imminent treatment
decisions. The treatment of children and adolescents with
differences of sex development is associated with bioethical
problems that derive from the prognostic uncertainty, the
time span of the prognosis, and the insufficiency of
available evidence interrelated with these factors; indeed,
the question of what exactly is in the best interest of the
child and of the respectively future adult can frequently not
be decided with certainty. Decisions made by parents as the
guardians of children not yet capable of giving consent
must be carefully weighed, given the breadth and scope of
the therapeutic decisions to be made. At the same time, it
must be kept in mind that the interests of the future adults—
although an important gauge for the clinical decision
making—are not automatically in concordance with the
interests of the child. For children, especially for small
children, a loving and trusting relationship with its parents
is of immense importance. Thus, caring for the parents and
fostering a good parent–child relationship is incumbent
upon all members of the multidisciplinary health-care team.
Their aim should be enabling the parents to deal with their
child in a responsible, loving, and relaxed manner.
Three ethical principles and/or rights can be delineated
here:
– foster the well-being of the child and the future adult.
This includes their bodily integrity and quality of life,
particularly with respect to reproductive capability as
well as ability to experience sex, and the free
development of their personality.
– uphold the rights of children and adolescents to
participate in and/or self-determine decisions that affect
them now or later. This includes the right of the future
adult to be comprehensively informed about their
condition and about all interventions carried out as
well as the multidisciplinary health-care team’s obliga-
tion to provide the appropriate information and
maintain documentation.
– respect the family and parent–child relationship. This
includes the rights and the duties of the parents to
represent their child in the decision-making process and
their right to receive professional support and assis-
tance from the multidisciplinary health-care team.
The aim shall be to achieve a balance between the rights,
needs, and interests as delineated.
Principles and recommendations for the multidisciplinary
health-care team
1. Differences of sex differentiation do not per se require
correction and for newborns, do not represent a surgical
emergency, but in general, a psychosocial one. Every
therapeutic decision that is not aimed at averting
imminent danger to the life and health of the child should
be weighed carefully without undue time constraints,
given due consideration to different options and be
reviewed scrupulously in consultation between members
of the multidisciplinary health-care team and the parents.
2. Right from the start, the multidisciplinary health-care
team must comprehensively involve the parents in the
decision-making and therapy-planning process and be
convinced that the parents have understood the planned
interventions, their significance, and scope. Legally, the
parents have the ultimate right to decide.
3. The child’s well-being is not automatically ensured by
determining an external and/or biologically unambiguous
sex. The development of the child’s self-confidence and
self-esteem regarding its personal and gender identity is a
therapeuticobjectiveofhighpriority.Indeed,thisisfirstly
achieved by supporting and accepting the child and
secondarily, at best by endowing the child with specific
bodily parts. The authors of these principles and
recommendations are aware that it is not always possible
to delineate clearly between functionally meaningful
interventions and those that serve purely esthetic correc-
tive functions—for example in the case of a genitoplasty
or vaginal reconstruction. Here, each case must be
weighed on its own merits. Whenever there is doubt, the
psychological and social support of the child and its
parents is to be ranked higher than the creation of
biological normalcy. Moreover, bringing up the child in
one gender without surgical esthetic correction reserves
for the child the option to change gender identity later if
deemednecessary.Whenassessingthechild’swell -bei ng,
any possible uncertainty or trauma relating to surgical
interventions, corrective measures, and repeated exami-
nations of the genital area should be given as much
consideration as potential limitations to their capacity to
experiencesexortotheirreproductivecapabilityasfuture
adults. Such aspects must be weighed against the benefits
to be gained for the child through an external or
biologically unambiguous sexual identity, given the fact
that the issue of surgical timing is contentious with regard
to achieving the optimal surgical outcome.
4. A therapeutic stance of openness and acceptance is to
be encouraged. This attitude has a long-lasting influ-
ence on the development of a good parent–child
relationship—an additional key therapeutic objective.
The family environment, the cultural context, and the
Eur J Pediatr (2010) 169:671–679 677preferred value system of the affected family must be
given due consideration. Special efforts should be made
to help parents cope with the associated conflicts. To
this end, parents should also be supplied with informa-
tion about self-help groups and similar organizations. In
line with their needs and wishes, the appropriate
contacts with the family should be liaised with, and/or
the family should be encouraged to make such contacts.
5. All interventions must be based upon the most
exhaustive diagnostics and the best possible prognosis
including the child’s and its family’s overall situation.
To do so, it is indispensable that specialists from
multiple disciplines hold mutual consultations. The less
evidence there is for a specific procedure, the more
important it is to seek additional expert opinions about
it. The team should always consist of competent
representatives from the fields of medicine, nursing,
psychology, and psychotherapy as well as social work-
ers. Overcoming one’s own feelings of shame and
unease is part of an appropriate professional stance.
6. Explicit reasoning and justification are necessary when
interventions are being considered that are not substan-
tiated by any satisfactorily conclusive scientific evi-
dence. A compelling medical indication is necessary for
interventions that might have irreversible consequences
for the person’s sex or negative consequences on their
sexuality or reproductive capability. Likewise, when
interventions that might have such consequences are
refrained from, explicit reasoning and justification are
required to back this up. In general, whenever prognos-
tically uncertain interventions can be delayed until the
child is old enough to make decisions for themselves, this
option should be presented to parents as the preference of
choice. As a rule, unless the child’sw e l l - b e i n gw o u l d
otherwise be severely impaired, decisions about the
removal of organs or structures important to an individ-
ual’s physicalintegrityorsexualidentity(suchasgonads)
should be left up to the affected persons themselves. If at
all, interventions that are not supported by sufficient
evidencearebestperformedunderstudyconditionsandat
specialized facilities.
7. The child should be given information about its
condition that is commensurate with its age. Its
participation in therapeutic decision making is an
indispensable part of treatment. This right should be
respected at the earliest possible stage. A child has veto
rights even at a very young age, whenever an
intervention is not urgent for the child’s health and
when it is plainly contrary to the child’s own will. The
older a child becomes, the more its opinion should be
observed and respected alongside that of the parents. In
general, once an adolescent reaches the age of 14, it has
the right to sole consent to a curative procedure. It is
imperative to ensure at all times that circumstances
commensurate with the child’s age are maintained
during examinations and treatments and that consider-
ation is given to the child’s feeling of shame. Geared to
its developmental level, the child should be given
partnership status and involved in all examination and
treatment steps accordingly.
8. The right of the future adult to obtain information about
the treatment it received during childhood must be
upheld through seamless documentation. Affected
persons capable of self-determination and/or their
parents should be told that they are entitled to inspect
their medical records. It is in the child’s interest to keep
detailed records of findings and treatments which are
important for full disclosure of medical interventions
later in life. All record keeping should be done with due
respect for the patient’s personal dignity and need for
privacy. Disclosure of findings to third parties for
purposes that imply no direct benefit for the affected
patient is only permissible after careful appraisal of the
advantages and disadvantages and always requires the
informed consent of the affected persons and/or of their
guardians. Data protection regulations must be scrupu-
lously observed during record keeping and archiving of
personal data in research projects.
9. These principles and recommendations should be
reviewed at regular intervals and adapted to the most
recent scientific and medical findings. Accompanying
ethical research should help evaluate whether they can
be feasibly put into practice and to what extent the
affected persons, their parents, or the health-care team
find them to be helpful and appropriate.
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